FindLaw Class Action and Mass Tort Center: Recalls: Food, Drugs and Medical Devices: absolutely certain
FDA Public Health Notification: Diathermy Interactions with Implanted Leads and Implanted Systems with Leads
FDA Public Health Notification: Diathermy Interactions with Implanted Leads and Implanted Systems with Leads
(You are encouraged to copy and distribute this Advisory)
December 19, 2002
Dear Colleague:
This is to alert you to the risk of serious injury or death if patients with
implanted electrical leads are exposed to diathermy treatments.
Background
Adverse events
FDA has received reports in which patients with implanted deep brain stimulators
(DBS) died after receiving diathermy therapy. One patient received diathermy
following oral surgery, the other for treatment of chronic scoliosis. In both
cases, the interaction of the diathermy with the implanted device caused severe
brain damage in the area where the lead electrodes were implanted.
Types of diathermy affected
There are three types of diathermy equipment used by physicians, dentists,
physical therapists, chiropractors, sports therapists, and others: radio frequency
(shortwave) diathermy, microwave diathermy and ultrasound diathermy. Shortwave
and microwave diathermy, in both heating and non-heating modes, can result
in serious injury or death to patients with implanted devices with leads.
This kind of interaction is not expected with ultrasound diathermy. Electrocautery
devices are not included in this notification.
Medical devices affected
Laboratory testing has shown that patients with any implanted
metallic lead are at risk of serious injury when exposed to shortwave or microwave
diathermy therapy. This is true even if the implanted device is not
turned on, and even if the lead is no longer connected to an implanted system.
Interaction of the diathermy energy with the implanted lead causes excessive
heating in the tissue surrounding the lead electrodes. Insufficient testing
has been done to determine whether there is a safe distance between the diathermy
applicator and the implant system that might allow patients to be treated
with diathermy without risk of injury.
Recommendations
Shortwave or microwave diathermy SHOULD NOT BE USED on patients who
have ANY implanted metallic lead, or any implanted system that may contain
a lead. Both the heating and non-heating modes of operation pose
a risk of tissue destruction.
If you are a physician who implants or monitors patients
with leads or implanted systems with leads:
If you are a health care professional who uses diathermy
(shortwave or microwave) in your practice:
-
Be sure to ask the patient about possible implants
before deciding to administer shortwave or microwave diathermy therapy.
If the patient has an implanted lead or an implant containing a lead, diathermy
therapy should not be used, even if the implant has been turned
off. Examples of implanted systems that may contain a lead include
cardiac pacemakers and defibrillators, cochlear implants, bone growth stimulators,
deep brain stimulators, spinal cord stimulators, and other nerve stimulators.
Reporting adverse events to FDA
The Safe Medical Devices Act of 1990 (SMDA) requires hospitals and other
user facilities to report deaths and serious injuries associated with the
use of medical devices. This means that if a patient death or serious injury
can possibly be attributable to a diathermy device, or attributable to interactions
of diathermy devices with any implanted device, you should follow the procedures
established by your facility for mandatory reporting.
If you have experienced problems with diathermy devices, or adverse events
involving interactions of diathermy devices with any implanted device, you
can report this directly to the manufacturer. Alternatively, you can report
directly to MedWatch, the FDA’s voluntary reporting program. You may
submit reports to MedWatch four ways: online to http://www.accessdata.fda.gov/scripts/medwatch/;
by telephone at 1-800-FDA-1088; by FAX at 1-800-FDA-0178; or by mail to MedWatch,
Food and Drug Administration, HF-2, 5600 Fishers Lane, Rockville, MD 20857.
Getting more information
If you have questions regarding this letter, please contact Marian Kroen,
Office of Surveillance and Biometrics (HFZ-510), 1350 Piccard Drive, Rockville,
Maryland, 20850, by fax at 301-594-2968, or by e-mail at phann@cdrh.fda.gov.
Additionally, a voice mail message may be left at 301-594-0650 and your call
will be returned as soon as possible.
| |
David W. Feigal, Jr., MD, MPH |
| |
Director |
| |
Center for Devices and Radiological Health |
| |
Food and Drug Administration |
Back to Safety Alert Page
Uploaded December 20, 2002

CDRH Home | Search
| A-Z
Index | Feedback | Accessibility
| Disclaimer
|